Q: Would appreciate your assessment of their Q4 and full year results that were released on 27 June.
Thanks as always.
Thanks as always.
5i Research Answer:
EPS of $0.02 missed estimates of $0.0583 and revenues of $43.96M missed estimates of $44.81M. Sales grew by 7%, but its SaaS revenue grew by 27% for the quarter, and its SaaS subscription bookings grew by 108%. Gross margins increased to 47% from 45% in the prior year, and management updated guidance for FY2025 calling for 7% to 9% revenue growth, 30% to 32% SaaS revenue growth nad 8% to 9% Adjusted EBITDA margins. It has a solid sales pipeline and management is emphasizing on refining its SaaS software, deepening its healthcare vertical, and expanding its footprint in the European markets. Overall, these were decent results and the stock is reacting positively to the numbers and guidance.